Antiviral effect of budesonide against SARS-CoV-2
N Heinen, TL Meister, M Klöhn, E Steinmann, D Todt… - Viruses, 2021 - mdpi.com
Treatment options for COVID-19, a disease caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection, are currently severely limited. Therefore, antiviral …
Coronavirus 2 (SARS-CoV-2) infection, are currently severely limited. Therefore, antiviral …
COVID-19 pneumonia: do not leave the corticosteroids behind!
SM Pinna, S Scabini, S Corcione, T Lupia… - Future …, 2021 - Taylor & Francis
The host inflammatory response is critical in the progression of lung injuries in patients with
SARS-CoV-2. Corticosteroids (CS) have been widely used as immunomodulating agents …
SARS-CoV-2. Corticosteroids (CS) have been widely used as immunomodulating agents …
Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
SARS-CoV-2 vaccines have been extremely effective in reducing the incidence of severe
coronavirus disease 2019 (COVID-19)[1, 2], but effective and safe treatments for acute …
coronavirus disease 2019 (COVID-19)[1, 2], but effective and safe treatments for acute …
Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice
ABSTRACT Introduction The SARS-COV-2 pandemic is a worldwide public health problem
due to the large medical burden and limited number of therapies available. Corticosteroids …
due to the large medical burden and limited number of therapies available. Corticosteroids …
[HTML][HTML] Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
S Ramakrishnan, DV Nicolau, B Langford… - The Lancet …, 2021 - thelancet.com
Background Multiple early reports of patients admitted to hospital with COVID-19 showed
that patients with chronic respiratory disease were significantly under-represented in these …
that patients with chronic respiratory disease were significantly under-represented in these …
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is characterized by a wide spectrum of symptom …
syndrome coronavirus 2 (SARS-CoV-2), is characterized by a wide spectrum of symptom …
Modulating the host immune response to fight against COVID-19: Where are we in 2021?
At present, while some countries are dealing with the continuously increasing incidence,
some of the others are currently facing the 2019 coronavirus disease (COVID-19) …
some of the others are currently facing the 2019 coronavirus disease (COVID-19) …
Inhaled corticosteroids for the treatment of COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused
severe illness and mortality for millions worldwide. Despite the development, approval and …
severe illness and mortality for millions worldwide. Despite the development, approval and …
Dexamethasone for severe COVID-19: how does it work at cellular and molecular levels?
The coronavirus disease 2019 (COVID-19) caused by infection of the severe respiratory
syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the …
syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the …
[HTML][HTML] A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms
In December 2019, a cluster of pneumonia caused by a novel coronavirus (2019-nCoV),
officially known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
officially known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …